<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04866914</url>
  </required_header>
  <id_info>
    <org_study_id>65743917.2.0000.0068</org_study_id>
    <nct_id>NCT04866914</nct_id>
  </id_info>
  <brief_title>Acceptance and Commitment Therapy for Insomnia</brief_title>
  <acronym>ACT-I</acronym>
  <official_title>Acceptance and Commitment Therapy for Chronic Insomnia in Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Insomnia is a frequent complaint and is associated with impairments in physical and&#xD;
      psychological health. Although Cognitive-Behavioral Therapy (CBT) demonstrates effective&#xD;
      results for insomnia, there are those who do not respond to this type of intervention or&#xD;
      present difficulties in adherence. Acceptance and Commitment Therapy (ACT) presents itself as&#xD;
      a potentially useful intervention for the treatment of insomnia, for which, instead of&#xD;
      focusing on controlling the symptoms, the respective approach focuses on accepting the&#xD;
      feelings and thoughts associated, through value-based actions. The aim of this study is to&#xD;
      evaluate the effectiveness of ACT for chronic insomnia in adults. Participants will be 150&#xD;
      adults aged between 18 and 59 years, diagnosed with chronic insomnia who will be randomly&#xD;
      assigned to the ACT, CBT and wait list (WL) groups. For both groups (ACT and CBT), the&#xD;
      intervention will be performed in six group and weekly sessions. Assessments of sleep&#xD;
      patterns, insomnia, depression, anxiety, psychological flexibility, acceptance of sleep,&#xD;
      beliefs about sleep, personality traits will be performed in the pre-treatment,&#xD;
      post-treatment and six-month follow-up. After the intervention is completed, participants&#xD;
      will respond to an inventory of compliance and satisfaction. The results will be compared&#xD;
      using mixed ANOVA, followed by multiple comparison tests, where appropriate. For the primary&#xD;
      and secondary outcomes, the magnitude of the effect will be calculated. The size of the&#xD;
      effect will be calculated using the square partial eta and d of Cohen.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 15, 2021</start_date>
  <completion_date type="Anticipated">December 20, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the score of Insomnia Severity Index (ISI)</measure>
    <time_frame>baseline, 7 weeks and 24 weeks after treatment commencement.</time_frame>
    <description>Change in the total score of Insomnia Severity Index (ISI)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction in Sleep Onset Latency (SOL)</measure>
    <time_frame>baseline, 7 weeks and 24 weeks after treatment commencement.</time_frame>
    <description>Reduction in Sleep Onset Latency (SOL) measured by sleep diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in Wake After Sleep Onset (WASO)</measure>
    <time_frame>baseline, 7 weeks and 24 weeks after treatment commencement.</time_frame>
    <description>Reduction in Wake After Sleep Onset (WASO) measured by sleep diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Increase in Total Sleep Time (TST)</measure>
    <time_frame>baseline, 7 weeks and 24 weeks after treatment commencement.</time_frame>
    <description>Increase in Total Sleep Time (TST) measured by sleep diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Increase in Sleep Efficiency (SE)</measure>
    <time_frame>baseline, 7 weeks and 24 weeks after treatment commencement.</time_frame>
    <description>Increase in Sleep Efficiency (SE) measured by sleep diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Hospital Anxiety and Depression Scale (HADS)</measure>
    <time_frame>baseline, 7 weeks and 24 weeks after treatment commencement.</time_frame>
    <description>Change in the total score for the anxiety variable (HADAS-A) and total score for the depression variable (HADAS-D)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Acceptance and Action Questionnaire-II (AAQ-II)</measure>
    <time_frame>baseline, 7 weeks and 24 weeks after treatment commencement.</time_frame>
    <description>Change in the the total score of Acceptance and Action Questionnaire-II (AAQ-II)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Sleep Problem Acceptance Questionnaire (SPAQ)</measure>
    <time_frame>baseline, 7 weeks and 24 weeks after treatment commencement.</time_frame>
    <description>Change in the the total score of Sleep Problem Acceptance Questionnaire (SPAQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Dysfunctional Beliefs and Attitudes about Sleep (DBAS-16)</measure>
    <time_frame>baseline, 7 weeks and 24 weeks after treatment commencement.</time_frame>
    <description>Change in the the total score of Dysfunctional Beliefs and Attitudes about Sleep (DBAS-16)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Insomnia</condition>
  <arm_group>
    <arm_group_label>ACT for Insomnia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>CBT for Insomnia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wait List</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Acceptance and Commitment Therapy for Insomnia</intervention_name>
    <description>ACT-I treatment group: Participants diagnosed with chronic insomnia will receive group treatment. The six sessions will be aimed at psychoeducation about sleep added to the therapeutic processes of acceptance, mindfulness, availability, values, defusion and commitment, used in ACT.</description>
    <arm_group_label>ACT for Insomnia</arm_group_label>
    <other_name>ACT-I</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Therapy for Insomnia</intervention_name>
    <description>Active control group CBT-I: Participants diagnosed with chronic insomnia will receive treatment in a group. The six sessions will be aimed at cognitive-behavioral components, such as education and sleep hygiene, stimulus control, sleep restriction and demystification / restructuring of belief beliefs.</description>
    <arm_group_label>CBT for Insomnia</arm_group_label>
    <other_name>CBT-I</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of chronic insomnia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Neurological degenerative disease&#xD;
&#xD;
          -  Psychotic disorder&#xD;
&#xD;
          -  sleep apnea, restless legs or periodic limb movements during sleep, or a&#xD;
             circadian-based sleep disorder (e.g., delayed or advanced sleep phase syndrome)&#xD;
&#xD;
          -  cognitive impairments&#xD;
&#xD;
          -  unavailability in attending the sessions.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>59 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>RENATHA RAFIHI-FERREIRA, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>UNIVERSITY OF SAO PAULO GENERAL HOSPITAL.</last_name>
    <phone>+55(11)26616518</phone>
    <email>renatha.rafihi@hc.fm.usp.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>PESQUISA ACT</last_name>
    <phone>+55(47)991810917</phone>
    <email>pesquisa.act.insonia@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Sao Paulo General Hospital.</name>
      <address>
        <city>São Paulo</city>
        <zip>05403903</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renatha Rafihi-Ferreira</last_name>
      <phone>+5547991810917</phone>
      <email>renatha.rafihi@hc.fm.usp.br</email>
    </contact>
    <investigator>
      <last_name>Renatha Rafihi-Ferreira, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 13, 2021</study_first_submitted>
  <study_first_submitted_qc>April 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 30, 2021</study_first_posted>
  <last_update_submitted>April 30, 2021</last_update_submitted>
  <last_update_submitted_qc>April 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>INSOMNIA</keyword>
  <keyword>acceptance and commitment therapy</keyword>
  <keyword>Cognitive behavioral therapy</keyword>
  <keyword>SLEEP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

